JFL LIFE SCIENCES LIMITED·Healthcare Companies·Pharmaceuticals & Biotechnology Companies

2026-08-21 NSE SME Web
SME₹65.4 K6,000
Result 10 Aug

Price

10.9

-2.68%
O:10.65
H:10.9
L:10.65
C:10.9

52W Range

8.5514.67
+27%/-26%

Market Cap

₹71.93 Cr

Traded: ₹0.04 Cr (0.05%) 0.0x

Free Float: ₹22.52 Cr (0.17% of FF traded)

Volume · 60D trend

36 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:-16% 3M:+19% 6M:+14% 12M:-0%

Valuation

P/E10.6
P/B1.6
P/S0.6
EV/EBIT59941505.2

Business Strength

ROE15.0%
ROCE18.2%
OPM9.2%
NPM4.6%

Growth (3Y CAGR)

EPS+54.0%
Sales+45.0%
Profit+32.0%
3Y Return-10.0%

Balance Sheet

Debt/Equity0.5
Debt21.7 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP-66.7%
FCF-7.71 Cr
FCF 3Y Avg-9.34 Cr
Cash/MCap1.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle165 days
Tradeable Free Float31.3%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
ROE
--
+13.0%
+12.0%
--
--
Decelerating
Return
--
--
-10.0%
-47.0%
--
Decelerating
Profit
--
+64.0%
+32.0%
--
+54.0%
Stable
Sales
--
+32.0%
+45.0%
--
+60.0%
Accelerating

Quarterly Results

Jun 2026

10 Aug
Rev
11 Cr
-4% YoY--
OPM18.8%
NPM--
PAT
--1 Cr
EPS
--0.2

Mar 2026

PDF
Rev
63 Cr
+438% YoY+135% QoQ
OPM5.6%
NPM2.6%
PAT
+1975% YoY2 Cr
EPS
+2400% YoY0.3

Dec 2025

PDF
Rev
27 Cr
+26% YoY-10% QoQ
OPM12.5%
NPM7.5%
PAT
+173% YoY2 Cr
EPS
+182% YoY0.3

Sep 2025

PDF
Rev
30 Cr
-24% YoY+158% QoQ
OPM9.7%
NPM6.6%
PAT
+36% YoY2 Cr
EPS
+36% YoY0.3

Jun 2025

PDF
Rev
12 Cr
+21% YoY-1% QoQ
OPM16.6%
NPM6.5%
PAT
-61% YoY1 Cr
EPS
-62% YoY0.1

Mar 2025

PDF
Rev
12 Cr
-46% YoY-45% QoQ
OPM11.8%
NPM0.7%
PAT
-93% YoY0 Cr
EPS
-94% YoY0.0

Dec 2024

PDF
Rev
21 Cr
---46% QoQ
OPM6.3%
NPM3.5%
PAT
--1 Cr
EPS
--0.1

Sep 2024

PDF
Rev
40 Cr
--+314% QoQ
OPM6.1%
NPM3.7%
PAT
--1 Cr
EPS
--0.2

Jun 2024

PDF
Rev
10 Cr
---56% QoQ
OPM32.1%
NPM20.0%
PAT
--2 Cr
EPS
--0.3

Mar 2024

PDF
Rev
22 Cr
----
OPM7.1%
NPM5.5%
PAT
--1 Cr
EPS
--0.2

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.48
Interest Coverage-1.3x
Promoter Pledge0.0%
Borrowings22 Cr

Efficiency

Receivable Days148 days
Inventory Days110 days
Payable Days93 days
Cash Conversion cycle165 days

Cash Position

Operating Cash Flow-4 Cr
Investing Cash Flow-4 Cr
Financing Cash Flow9 Cr
Free Cash Flow-8 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Sales11632730121221401022
Expenses960232710102037620
Operating Profit2433211232
OPM %18.8%5.6%12.5%9.7%16.6%11.8%6.3%6.1%32.1%7.1%
Other Income0000000000
Interest0100000000
Depreciation0000000000
Profit Before Tax1232111231
Tax %25.5%26.2%25.1%10.9%48.3%87.0%25.3%23.2%25.4%13.1%
Net Profit1222101121
Exceptional Items--------------------
EPS (Rs)0.20.30.30.30.10.00.10.20.30.2
Sales Growth (YoY)-4.2%437.5%26.3%-24.3%21.5%-45.9%--------
Sales Growth (QoQ)--134.9%-10.3%158.1%-1.2%-44.8%-46.2%314.1%-56.0%--
OP Growth (YoY)8.3%154.3%148.1%20.7%-36.9%-11.0%--------
OP Growth (QoQ)-40.5%4.8%15.1%50.8%39.9%2.2%-44.0%-21.2%97.4%--
Profit Growth (YoY)--1975.0%173.0%36.0%-61.0%-93.0%--------
EPS Growth (YoY)--2400.0%181.8%36.4%-62.1%-94.4%--------
EPS Growth (QoQ)---19.4%3.3%172.7%1000.0%-90.9%-50.0%-24.1%61.1%--
OP Margin--5.6%12.5%9.7%16.6%11.8%6.3%6.1%32.1%7.1%
Net Margin--2.6%7.5%6.6%6.5%0.7%3.5%3.7%20.0%5.5%
Material Cost %--92.0%86.0%89.0%66.0%65.0%89.0%93.0%57.0%91.0%
Employee Cost %--1.0%1.0%1.0%2.0%2.0%1.0%1.0%6.0%1.0%
P/S0.550.70----------------
P/E10.5814.28----------------
P/B1.561.99----------------

Shareholding Pattern

Shareholders:971 (-0.7%)
Current MixMar 2026

Annual Reports

3

2025

2024

2023